The report on Cold Chain for Pharmaceutical market offers an overview of several major countries spread across various geographic regions over the globe. The report concentrates on recognizing various market developments, dynamics, growth drivers and factors hampering the market growth. Further, the report delivers comprehensive insights into numerous growth opportunities and challenges based on various types of products, applications, end users and countries, among others.

Key Market Players
According to the global Cold Chain for Pharmaceutical market analysis, the key players operating include

Deutsche Post
FedEx
Biotec Services
UPS
Nichirei Logistics Group
Air Canada Cargo
Helapet
Igloo Thermo-Logistics
Kerry Logistics
XPO Logistics
Cold Chain Technologies
Continental Air Cargo
Lineage Logistics
OOCL Logistics
SCG Logistics
JWD Group
Swire Group
Burris Logistics
VersaCold Logistics Services
LifeConEx
Marken
Nordic Cold Storage
Panalpina World Transport
Sofrigam

Report Scope:
A complete interpretation of the global Cold Chain for Pharmaceutical market

Attractive investment plans in the global Cold Chain for Pharmaceutical market based on various segments such as product type, application, end user etc.
Important success factors and pain points in the form of growth drivers and restraints leading the market outlook along with future trend examination
In depth company profiles offering insights into their product offerings, strategies, revenue information and latest market activities
Information on industry value chain analysis of the global Cold Chain for Pharmaceutical market providing an analytical study of key stakeholders involved, which could advance market participants in formulating appropriate strategies
Competitive landscape of the global Cold Chain for Pharmaceutical market and market share analysis based on company’s performance and customer reach

Report Overview:
This study was conducted with a global viewpoint in terms of the various segments in the Cold Chain for Pharmaceutical market. Market sizing and estimate have been conducted for 5 geographic regions: North America, Latin America, Europe, Middle East and Africa (MEA), and Asia-Pacific. All market sizing information is delivered in US$ with historic data for 2018 and 2019, along with valuations and forecast for the period from 2020 to 2028.
Apart from that, the report also provides important distinguishing information regarding each of the market segments. These segments are analyses further on different fronts such as historical performance, market size contributions, % market share, expected rate of growth.

COVID-19 Impact:
The report provides how this industry is likely to be impacted as a result of the global COVID-19 pandemic. Market value by revenue is expected to develop xx% in 2020 alone as demand is expected to be reasonably affected by the outbreak of COVID-19. The downstream companies contend with limited profit from falling consumer confidence, demand for industry products is expected to slow. Demand from top notch companies and government agencies is expected to grow as they seek more data on COVID-19. Almost, every sector is anticipated to be impacted by COVID-19 pandemic. Some of the industries are struggling and some are thriving.

Key Market Segmentation:
Cold Chain for Pharmaceutical Market, by Type:

Refrigerated Storage
Cold Chain Logistics

Cold Chain for Pharmaceutical Market, by Application:

Pharmaceuticals
Blood Goods
Other

Cold Chain for Pharmaceutical Market, by Geography:
On the basis of region, the global Cold Chain for Pharmaceutical market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regional segmentation consists of the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East and Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

1 Cold Chain for Pharmaceutical Market Overview
1.1 Product Overview and Scope of Cold Chain for Pharmaceutical
1.2 Cold Chain for Pharmaceutical Segment by Type
1.2.1 Global Cold Chain for Pharmaceutical Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Refrigerated Storage
1.2.3 Cold Chain Logistics
1.3 Cold Chain for Pharmaceutical Segment by Application
1.3.1 Cold Chain for Pharmaceutical Sales Comparison by Application: (2020-2026)
1.3.2 Pharmaceuticals
1.3.3 Blood Goods
1.3.4 Other
1.4 Global Cold Chain for Pharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Cold Chain for Pharmaceutical Revenue 2015-2026
1.4.2 Global Cold Chain for Pharmaceutical Sales 2015-2026
1.4.3 Cold Chain for Pharmaceutical Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Cold Chain for Pharmaceutical Industry Impact
1.5.1 How the Covid-19 is Affecting the Cold Chain for Pharmaceutical Industry
1.5.1.1 Cold Chain for Pharmaceutical Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Cold Chain for Pharmaceutical Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures/Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Cold Chain for Pharmaceutical Players to Combat Covid-19 Impact
1.6 Study Objectives
1.7 Years Considered

2 Global Cold Chain for Pharmaceutical Market Competition by Manufacturers
2.1 Global Cold Chain for Pharmaceutical Sales Market Share by Manufacturers (2015-2020)
2.2 Global Cold Chain for Pharmaceutical Revenue Share by Manufacturers (2015-2020)
2.3 Global Cold Chain for Pharmaceutical Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Cold Chain for Pharmaceutical Manufacturing Sites, Area Served, Product Type
2.5 Cold Chain for Pharmaceutical Market Competitive Situation and Trends
2.5.1 Cold Chain for Pharmaceutical Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Cold Chain for Pharmaceutical Players (Opinion Leaders)

3 Cold Chain for Pharmaceutical Retrospective Market Scenario by Region
3.1 Global Cold Chain for Pharmaceutical Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Cold Chain for Pharmaceutical Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Cold Chain for Pharmaceutical Market Facts & Figures by Country
3.3.1 North America Cold Chain for Pharmaceutical Sales by Country
3.3.2 North America Cold Chain for Pharmaceutical Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cold Chain for Pharmaceutical Market Facts & Figures by Country
3.4.1 Europe Cold Chain for Pharmaceutical Sales by Country
3.4.2 Europe Cold Chain for Pharmaceutical Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cold Chain for Pharmaceutical Market Facts & Figures by Region
3.5.1 Asia Pacific Cold Chain for Pharmaceutical Sales by Region
3.5.2 Asia Pacific Cold Chain for Pharmaceutical Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cold Chain for Pharmaceutical Market Facts & Figures by Country
3.6.1 Latin America Cold Chain for Pharmaceutical Sales by Country
3.6.2 Latin America Cold Chain for Pharmaceutical Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cold Chain for Pharmaceutical Market Facts & Figures by Country
3.7.1 Middle East and Africa Cold Chain for Pharmaceutical Sales by Country
3.7.2 Middle East and Africa Cold Chain for Pharmaceutical Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Cold Chain for Pharmaceutical Historic Market Analysis by Type
4.1 Global Cold Chain for Pharmaceutical Sales Market Share by Type (2015-2020)
4.2 Global Cold Chain for Pharmaceutical Revenue Market Share by Type (2015-2020)
4.3 Global Cold Chain for Pharmaceutical Price Market Share by Type (2015-2020)
4.4 Global Cold Chain for Pharmaceutical Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Cold Chain for Pharmaceutical Historic Market Analysis by Application
5.1 Global Cold Chain for Pharmaceutical Sales Market Share by Application (2015-2020)
5.2 Global Cold Chain for Pharmaceutical Revenue Market Share by Application (2015-2020)
5.3 Global Cold Chain for Pharmaceutical Price by Application (2015-2020)

6 Company Profiles and Key Figures in Cold Chain for Pharmaceutical Business
6.1 Deutsche Post
6.1.1 Corporation Information
6.1.2 Deutsche Post Description, Business Overview
6.1.3 Deutsche Post Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Deutsche Post Products Offered
6.1.5 Deutsche Post Recent Development
6.2 FedEx
6.2.1 Corporation Information
6.2.2 FedEx Description, Business Overview
6.2.3 FedEx Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.2.4 FedEx Products Offered
6.2.5 FedEx Recent Development
6.3 Biotec Services
6.3.1 Corporation Information
6.3.2 Biotec Services Description, Business Overview
6.3.3 Biotec Services Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Biotec Services Products Offered
6.3.5 Biotec Services Recent Development
6.4 UPS
6.4.1 Corporation Information
6.4.2 UPS Description, Business Overview
6.4.3 UPS Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.4.4 UPS Products Offered
6.4.5 UPS Recent Development
6.5 Nichirei Logistics Group
6.5.1 Corporation Information
6.5.2 Nichirei Logistics Group Description, Business Overview
6.5.3 Nichirei Logistics Group Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Nichirei Logistics Group Products Offered
6.5.5 Nichirei Logistics Group Recent Development
6.6 Air Canada Cargo
6.6.1 Corporation Information
6.6.2 Air Canada Cargo Description, Business Overview
6.6.3 Air Canada Cargo Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Air Canada Cargo Products Offered
6.6.5 Air Canada Cargo Recent Development
6.7 Helapet
6.7.1 Corporation Information
6.7.2 Helapet Description, Business Overview
6.7.3 Helapet Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.7.4 Helapet Products Offered
6.7.5 Helapet Recent Development
6.8 Igloo Thermo-Logistics
6.8.1 Corporation Information
6.8.2 Igloo Thermo-Logistics Description, Business Overview
6.8.3 Igloo Thermo-Logistics Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Igloo Thermo-Logistics Products Offered
6.8.5 Igloo Thermo-Logistics Recent Development
6.9 Kerry Logistics
6.9.1 Corporation Information
6.9.2 Kerry Logistics Description, Business Overview
6.9.3 Kerry Logistics Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Kerry Logistics Products Offered
6.9.5 Kerry Logistics Recent Development
6.10 XPO Logistics
6.10.1 Corporation Information
6.10.2 XPO Logistics Description, Business Overview
6.10.3 XPO Logistics Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.10.4 XPO Logistics Products Offered
6.10.5 XPO Logistics Recent Development
6.11 Cold Chain Technologies
6.11.1 Corporation Information
6.11.2 Cold Chain Technologies Description, Business Overview
6.11.3 Cold Chain Technologies Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Cold Chain Technologies Products Offered
6.11.5 Cold Chain Technologies Recent Development
6.12 Continental Air Cargo
6.12.1 Corporation Information
6.12.2 Continental Air Cargo Description, Business Overview
6.12.3 Continental Air Cargo Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Continental Air Cargo Products Offered
6.12.5 Continental Air Cargo Recent Development
6.13 Lineage Logistics
6.13.1 Corporation Information
6.13.2 Lineage Logistics Description, Business Overview
6.13.3 Lineage Logistics Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Lineage Logistics Products Offered
6.13.5 Lineage Logistics Recent Development
6.14 OOCL Logistics
6.14.1 Corporation Information
6.14.2 OOCL Logistics Description, Business Overview
6.14.3 OOCL Logistics Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.14.4 OOCL Logistics Products Offered
6.14.5 OOCL Logistics Recent Development
6.15 SCG Logistics
6.15.1 Corporation Information
6.15.2 SCG Logistics Description, Business Overview
6.15.3 SCG Logistics Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.15.4 SCG Logistics Products Offered
6.15.5 SCG Logistics Recent Development
6.16 JWD Group
6.16.1 Corporation Information
6.16.2 JWD Group Description, Business Overview
6.16.3 JWD Group Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.16.4 JWD Group Products Offered
6.16.5 JWD Group Recent Development
6.17 Swire Group
6.17.1 Corporation Information
6.17.2 Swire Group Description, Business Overview
6.17.3 Swire Group Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Swire Group Products Offered
6.17.5 Swire Group Recent Development
6.18 Burris Logistics
6.18.1 Corporation Information
6.18.2 Burris Logistics Description, Business Overview
6.18.3 Burris Logistics Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Burris Logistics Products Offered
6.18.5 Burris Logistics Recent Development
6.19 VersaCold Logistics Services
6.19.1 Corporation Information
6.19.2 VersaCold Logistics Services Description, Business Overview
6.19.3 VersaCold Logistics Services Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.19.4 VersaCold Logistics Services Products Offered
6.19.5 VersaCold Logistics Services Recent Development
6.20 LifeConEx
6.20.1 Corporation Information
6.20.2 LifeConEx Description, Business Overview
6.20.3 LifeConEx Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.20.4 LifeConEx Products Offered
6.20.5 LifeConEx Recent Development
6.21 Marken
6.21.1 Corporation Information
6.21.2 Marken Description, Business Overview
6.21.3 Marken Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.21.4 Marken Products Offered
6.21.5 Marken Recent Development
6.22 Nordic Cold Storage
6.22.1 Corporation Information
6.22.2 Nordic Cold Storage Description, Business Overview
6.22.3 Nordic Cold Storage Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.22.4 Nordic Cold Storage Products Offered
6.22.5 Nordic Cold Storage Recent Development
6.23 Panalpina World Transport
6.23.1 Corporation Information
6.23.2 Panalpina World Transport Description, Business Overview
6.23.3 Panalpina World Transport Cold Chain for Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.23.4 Panalpina World Transport Products Offered
6.23.5 Panalpina World Transport Recent Development

7 Cold Chain for Pharmaceutical Manufacturing Cost Analysis
7.1 Cold Chain for Pharmaceutical Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cold Chain for Pharmaceutical
7.4 Cold Chain for Pharmaceutical Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cold Chain for Pharmaceutical Distributors List
8.3 Cold Chain for Pharmaceutical Customers

9 Market Dynamics
9.1 Market Overview
9.2 Market Trends
9.3 Market Inclination Insights Analysis
9.4 Drivers
9.5 Opportunities
9.6 Challenges
9.7 Future Prospects
9.8 Impact Analysis of Drivers and Challenges During the Forecast Period, (2018-2028)

10 Global Market Forecast
10.1 Global Cold Chain for Pharmaceutical Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cold Chain for Pharmaceutical by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Cold Chain for Pharmaceutical by Type (2021-2026)
10.2 Cold Chain for Pharmaceutical Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cold Chain for Pharmaceutical by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Cold Chain for Pharmaceutical by Application (2021-2026)
10.3 Cold Chain for Pharmaceutical Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cold Chain for Pharmaceutical by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Cold Chain for Pharmaceutical by Region (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

1632

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

1632

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

1632

Client base spread across 100+ countries - including 20% of Fortune 500 companies and 3000+ SMEs
4 Million+ Hours of Research Experience including 350+ Client Queries Handled Each Day
Incisive Insights into Market Dynamics – 2 Million+ Data Points, 1.2 Mn+ New Data Points Captured Each Year
Deeper Study, Minimal Assumptions – Years of Expertise and Diligence Incorporated

Our Research Methodology is based on the following main points:

Data Collections and Interpretation
Analysis
Data Validation
Final Projections and Conclusion

SELECT USER FORMAT

Single User: It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.
$2350
Multi User : It allows the purchased product to be shared among 5 people within your organization at maximum.
$3350
Corporate User : It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.
$4350

Why Zeal Insider?

Inflallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

Global Cold Chain for Pharmaceutical Market By Product Type (Refrigerated Storage, Cold Chain Logistics) And By End-Users/Application (Pharmaceuticals, Blood Goods) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

SELECT USER FORMAT

Why Zeal Insider?

Inflallible Methodology

Analyst Support

Customization

Targeted Market View

OUR CLIENT

About Company

Need Help

Contact Us

About Us